Synthesis and biological evaluation of piperidyl benzimidazole carboxamide derivatives as potent PARP-1 inhibitors and antitumor agents

查看全文 作　　者：Xinwei [1,2]Zhang;Cunlong [3]Zhang;Lin [3]Tang;Kuan [3]Lu;Huan [4]Zhao;Weibin [3]Wu;Yuyang [2,5]Jiang 机构地区：[1]Department of Chemistry,Tsinghua University,Beijing 100084,China;[2]The State Key Laboratory of Chemical Oncogenomics,Key Laboratory of Chemical Biology,The Graduate School at Shenzhen,Tsinghua University,Shenzhen 518055,China;[3]Shenzhen Kivita Innovative Drug Discovery Institute,Shenzhen 518057,China;[4]Shenzhen Ruikang Pharmaceutical Technology Co.,Ltd.,Shenzhen 518057,China;[5]Department of Pharmacology and Pharmaceutical Sciences,School of Medicine,Tsinghua University,Beijing 100084,China 出　　处：《Chinese Chemical Letters》索引2020年第31卷第1期,共5页 基　　金：Shenzhen Sci.& Tech.Bureau (Nos.JCYJ20170816170342439 and JCYJ20170413113448742) for the financial supports 摘　　要：We have synthesized a series of compounds based on a piperidyl benzimidazole carboxamide structure,and tested their PARP-1 inhibitory activity,as well as cellular inhibitory activity.Some of them show great potency as PARP-1 inhibitors and antitumor activity,which are valuable for further research.In addition,the predicted ADME properties and proposed binding mode with PARP-1 of the compounds were obtained via computational simulation. 关 键 词：PARP-1 inhibitor Piperidyl benzimidazole carboxamide A-620223 Structure-activity relationship Antitumor activity